Xijing Hospital
Clinical trials sponsored by Xijing Hospital, explained in plain language.
-
New hope for shrinking tough stomach tumors before surgery
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called zanidatamab to standard chemotherapy can better shrink tumors before surgery in people with locally advanced HER2-positive stomach or gastroesophageal junction cancer. The goal is to see if this combination leads to…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Study tests whether watching small thyroid cancers is safer than surgery
Disease control Not yet recruitingThis study follows people with very small, low-risk thyroid cancers to compare three different approaches: surgery, a heat-based treatment called ablation, or simply monitoring with regular check-ups. Researchers will track how safe each option is and how it affects people's qual…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat breast cancer: testing a Triple-Drug attack
Disease control Not yet recruitingThis study is testing a new combination of three drugs (neratinib, fulvestrant, and eribulin) for people with a specific type of advanced breast cancer. It is for patients whose cancer has continued to grow despite treatment with a common drug called trastuzumab deruxtecan. The g…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Skin study tests if cutting out mole helps fade white patches
Disease control Not yet recruitingThis study aims to find the better treatment for a skin condition where a mole is surrounded by a white patch (vitiligo). It will compare two approaches in 60 participants aged 6-45: surgically removing the central mole followed by medication, versus using medication alone. Resea…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duo aims to wipe out breast cancer before surgery
Disease control Not yet recruitingThis study is testing whether a combination of two newer drugs, serplulimab and SHR-A1811, can effectively shrink tumors in patients with early-stage triple-negative breast cancer before they have surgery. The goal is to see if this non-chemotherapy approach can completely elimin…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can changing how we feed stroke patients save lives?
Disease control Not yet recruitingThis study aims to find out if feeding severe stroke patients in scheduled bursts (intermittent) is better than a steady drip (continuous) for improving survival and recovery. It will involve 60 patients and track their health, nutrition, and side effects over 90 days. Researcher…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New drug may speed up recovery after colon surgery
Symptom relief Not yet recruitingThis study aims to see if a newer drug (sugammadex) helps patients recover their bowel function faster after colon surgery compared to the standard drug combination (neostigmine/atropine). It will involve 560 adults having planned colon surgery. The main goal is to see if more pa…
Phase: PHASE3 • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
New drug aims to ease pain without slowing gut after spine surgery
Symptom relief Not yet recruitingThis study is testing a new pain medication called oliceridine for patients recovering from lower back surgery. Researchers want to see if it controls pain as well as morphine but causes fewer side effects like constipation and slowed digestion. The goal is to help patients feel …
Phase: NA • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC
-
Could a simple blood test predict your Vitiligo's future?
Knowledge-focused Not yet recruitingThis study aims to create a tool to better predict how vitiligo will progress and respond to treatment. Researchers will collect blood samples from 100 people with vitiligo and 25 healthy people to measure specific immune system markers called cytokines. By tracking these markers…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists track Brain's hidden signals to predict stroke recovery
Knowledge-focused Not yet recruitingThis study aims to understand why stroke recovery varies so much, even after successful treatment. Researchers will monitor 180 patients who have had a clot removed, tracking their brain and nerve signals during the first week. The goal is to find patterns in these signals that c…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC